Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for prevention of sufentanil-induced cough
ChiCTR1900023984Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Cough incidence and Cough intensity. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
nalbuphine
Beyond the preview
Go deeper on ChiCTR1900023984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023984.